Global TTO Panel: Success Stories of Commercialization
PatSnap presents The TTO as Wellspring: Commercialized Technology Success Stories as part of Frontier 2021.
Last week we announced our new Innovation Academy ‘Academic in Residence’ program. The purpose of this initiative is to enhance the content and resources we provide aspiring and professional innovators.
Joe Sekhon, Senior Lecturer in Intellectual Property (IP) at Portsmouth University, an entrepreneur, and the Founder of iPass (Intellectual Property Advice for Student Start-ups), is at the helm of this program as our Lead Academic in Residence.
With Joe’s assistance, we are bringing together Technology Transfer Offices (TTOs) from a number of universities to discuss some of the best ways TTOs have partnered with companies to commercialize research and innovation.
To learn more about TTOs and how to find the right Academic partners, join us for Frontier 2021, an annual user conference curated to connect the world’s brightest, most innovative minds. Our panel discussion, The TTO as Wellspring: Commercialized Technology Success Stories, will discuss examples of commercialization through partnerships including how to build mutually beneficial relationships, measure success, pitfalls to avoid, and advice on how to make it work.
This panel features a diverse group of experts including:
- Joe Sekhon (chair), Senior Lecturer in IP at University of Portsmouth
- Karen Temple, Commercialization Manager, University of Toronto
- Curtis Broadbent, Licensing Manager, University of Rochester
- Mark Barber, Commercialization Manager, University of Portsmouth
Happening on October 14th, at 1pm EST. Reserve your spot at Frontier now. We look forward to seeing you there!
Join us on October 14th, at 1pm EST to hear about TTOs from the global community.
Your recommended content
-
Meet Hiro Life Sciences: Your Trusted AI Assistant for Accelerated Drug Discovery
Category: Article | Category: Drug Discovery | Category: life sciences
Tuesday, November 26, 2024
AI is revolutionizing drug discovery by providing rapid access to vast and complex datasets, enabling researchers to quickly uncover valuable insights and connections that would be otherwise difficult to observe. By automating routine tasks, enabling advanced analytics, and streamlining workflows, AI is poised to make the entire R&D process significantly more efficient.
-
Patsnap Surpasses US$100 Million in Annual Recurring Revenue
Category: Article | Category: News/PR
Wednesday, June 12, 2024
Patsnap has reached a significant milestone of achieving $100M in Annual Recurring Revenue (ARR), marking an impressive 20% year-over-year growth in 2023. This milestone highlights the massive and meaningful value our platform brings to over 12,000 IP and R&D teams across 50 countries, driving efficiency, productivity, and collaboration.
-
Introducing Hiro, an AI assistant built for IP and R&D workflows
Category: AI advancements | Category: AI development | Category: AI-tools | Category: Article | Category: artificial intelligence
Tuesday, May 14, 2024
Powered by Patsnap’s industry-specific LLM, Hiro is designed to streamline IP and R&D workflows from ideation to product launch. With its robust AI capabilities, Hiro brings a new level of efficiency, precision, and security to tasks that were once time-consuming and labor-intensive.What sets Hiro apart is that it draws from our large language model that’s been trained on market-leading patent records, academic papers, and proprietary innovation data. This ensures we deliver more accurate and reliable results for every prompt.
